Change of Director's Interest Notice - Simon Panton
Released
Released
Announcement PDF
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX
becomes ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for
the purposes of section 205G of the Corporations Act.
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Appendix 3Y
Change of Director's Interest Notice
Name of entity RESONANCE HEALTH LIMITED
ABN 96 006 762 492
Name of director Simon Panton
Date of last notice 27 June 2025
Direct or indirect interest (1) Indirect - The Design Counsel Pty Ltd
(2) Indirect - Southam Investments 2003 Pty Ltd
Nature of indirect interest
(including registered holder)
(1) Entity controlled by Simon Panton's wife
(2) Entity controlled by Simon Panton
Date of change (1)(a) 26 November 2025
(1)(b) 27 November 2025
(2) N/A
No. of securities held prior to change (1) 546,350 - ORDINARY FULLY PAID SHARES
(2) 74,800,000 - ORDINARY FULLY PAID SHARES
Class (1) ORDINARY FULLY PAID SHARES
(2) ORDINARY FULLY PAID SHARES
Number acquired (1)(a) 369,761 ORDINARY FULLY PAID SHARES
on 26 Nov 2025
(1)(b) 53,761 ORDINARY FULLY PAID SHARES on
27 Nov 2025
(2) NIL
Number disposed (1) NIL
(2) NIL
Value/Consideration (1)(a) $17,748.53 (0.048 per share)
(1)(b) $2,580.53 (0.048 per share)
(2) N/A
+
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Part 2 - Change of director's relevant interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Part 3 - +Closed period
Appendix 3Y
Change of Director's Interest Notice
No. of securities held after change (1) 969,872 - ORDINARY FULLY PAID SHARES
(2) 74,800,000 - ORDINARY FULLY PAID SHARES
Nature of change (1) N/A
(2) N/A
Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities
to which interest related
prior to change
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Interest after change N/A
Were the interests in the securities or
contracts detailed above traded during a
+
closed period where prior written clearance
was required?
No
If so, was prior written clearance provided to
allow the trade to proceed during this period?
N/A
If prior written clearance was provided, on
what date was this provided?
N/A
+
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 2
Share your feedback
Discover